Associate Nicole DeAbrantes ("Nikki") will serve as a panelist on the session "Navigating the Funding Freeze Fallout: The Impact of NIH Grant Cuts on Life Sciences R&D and Updates on Ensuing Legal Challenges" at American Conference Institute's (ACI) 12th Annual Summit for Women Leaders in Life Sciences Law taking place July 30-31, 2025, in Boston, Massachusetts.
With over $4 billion in halted NIH grants and defunded university programs, clinical trials and scientific innovation are facing unprecedented disruption. As legal challenges mount, life sciences leaders and legal professionals must navigate the fallout. Nikki and her co-panelists will discuss:
- The impacts of halted funding on clinical trials and drug development;
- Analyzing ongoing lawsuits against the NIH and updates on the broader legal fight to restore funding;
- The consequences of defunding universities and health equity programs on future medical breakthroughs; and
- How life sciences companies and legal advisors can respond to the disruption, from compliance strategies to managing potential private litigation risks.
ACI’s Summit for Women Leaders in Life Sciences Law is dedicated to providing the invaluable opportunities for networking and collaboration with the chance to meet, engage with, and learn from over 300 attorneys and executives from the biotech, pharmaceutical, and medical device industries and keep attendees up-to-date on the latest developments and challenges in the industry.
Rothwell Figg is a proud sponsor of the event.
To learn more, please visit the ACI Summit for Women Leaders in Life Sciences Law website.
